Verve Therapeutics Price on February 4, 2025
| VERVDelisted Stock | USD 11.13 0.00 0.00% |
If you're considering investing in Verve Stock, it is important to understand the factors that can impact its price. As of today, the current price of Verve Therapeutics stands at 11.13, as last reported on the 6th of August, with the highest price reaching 11.13 and the lowest price hitting 11.13 during the day. Verve Therapeutics is risky given 3 months investment horizon. Verve Therapeutics owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.18, which indicates the firm had a 0.18 % return per unit of risk over the last 3 months. We were able to interpolate data for twenty-five different technical indicators, which can help you to evaluate if expected returns of 2.11% are justified by taking the suggested risk. Use Verve Therapeutics Risk Adjusted Performance of 0.1247, coefficient of variation of 694.9, and Semi Deviation of 2.98 to evaluate company specific risk that cannot be diversified away.
Verve Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
Verve |
Verve Therapeutics Valuation on February 4, 2025
It is possible to determine the worth of Verve Therapeutics on a given historical date. On February 4, 2025 Verve was worth 7.9 at the beginning of the trading date compared to the closed value of 8.06. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Verve Therapeutics stock. Still, in general, we apply an absolute valuation method to find Verve Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Verve Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Verve Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 7.30 | 7.57 | 6.95 | 7.52 | 1,316,845 | |
02/04/2025 | 7.90 | 8.22 | 7.57 | 8.06 | 2,199,486 |
| 8.21 | 8.77 | 8.15 | 8.63 | 1,931,860 |
| Backtest Verve Therapeutics | | | Verve Therapeutics History | | | Verve Therapeutics Valuation | Previous | Next |
Verve Therapeutics Trading Date Momentum on February 4, 2025
| On February 05 2025 Verve Therapeutics was traded for 8.63 at the closing time. The top price for the day was 8.77 and the lowest listed price was 8.15 . The trading volume for the day was 1.9 M. The trading history from February 5, 2025 was a factor to the next trading day price increase. The trading price change against the next closing price was 7.07% . The trading price change against the current closing price is 2.98% . |
Verve Therapeutics Fundamentals Correlations and Trends
By evaluating Verve Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Verve Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Verve financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Verve Therapeutics Stock history
Verve Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Verve is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Verve Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Verve Therapeutics stock prices may prove useful in developing a viable investing in Verve Therapeutics
Verve Therapeutics, Inc., a genetic medicines company, engages in developing gene editing medicines for patients to treat cardiovascular diseases. Verve Therapeutics, Inc. was incorporated in 2018 and is headquartered in Cambridge, Massachusetts. Verve Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 113 people.
Verve Therapeutics Stock Technical Analysis
Verve Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
Price Boundaries
Verve Therapeutics Period Price Range
Low | August 6, 2025
| High |
0.00 | 0.00 |
Verve Therapeutics cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Verve Therapeutics August 6, 2025 Market Strength
Market strength indicators help investors to evaluate how Verve Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Verve Therapeutics shares will generate the highest return on investment. By undertsting and applying Verve Therapeutics stock market strength indicators, traders can identify Verve Therapeutics entry and exit signals to maximize returns
Verve Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Verve Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Verve Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Verve to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1247 | |||
| Jensen Alpha | 1.48 | |||
| Total Risk Alpha | 0.0194 | |||
| Sortino Ratio | 0.3515 | |||
| Treynor Ratio | 2.73 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Other Consideration for investing in Verve Stock
If you are still planning to invest in Verve Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Verve Therapeutics' history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |